Senior insider sale
President & CEO at LYRA THERAPEUTICS, INC. — senior position signals high conviction
$3.9K
537.00 shares
What this filing means
PALASIS MARIA plans to sell 537.00 shares of LYRA THERAPEUTICS, INC. valued at approximately $3.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/14/2025ACC: 0001959173-25-006439
DirectorOfficer· President & CEO
Since Apr 2020
537.00
Shares to sell
$3.9K
Approx. market value
537.00
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
10/1/2025
537.00Total acquired537.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/1/2025 | Restricted Stock Vesting Compensation | 537.00 | — |
| Total | 537.00 | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
537.00
Market value
$3.9K
10/14/2025
Total
Units
537.00
Value
$3.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
10/14/2025 | 537.00 | $3.9K | NASDAQ | Planned |
| Total | 537.00 | $3.9K | ||